174 related articles for article (PubMed ID: 35728771)
1. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
2. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
3. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer.
Zhao A; Guo L; Xu J; Zheng L; Guo Z; Ling Z; Wang L; Mao W
Cancer Med; 2019 Jul; 8(7):3566-3574. PubMed ID: 31099496
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
He Z; Li W; Zheng T; Liu D; Zhao S
J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
7. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer.
Wang X; Zhong W; Bu J; Li Y; Li R; Nie R; Xiao C; Ma K; Huang X; Li Y
Mol Carcinog; 2019 May; 58(5):674-685. PubMed ID: 30604894
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing of exosomes revealed differentially expressed long noncoding RNAs in early-stage esophageal squamous cell carcinoma and benign esophagitis.
Tian L; Yang L; Zheng W; Hu Y; Ding P; Wang Z; Zheng D; Fu L; Chen B; Xiao T; Wang Y; Chen F; Liu J; Gao K; Shen S; Zhai R
Epigenomics; 2020 Mar; 12(6):525-541. PubMed ID: 32043367
[No Abstract] [Full Text] [Related]
9. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
[TBL] [Abstract][Full Text] [Related]
10. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
Shi Z; Jiang T; Cao B; Sun X; Liu J
Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
12. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.
Matsumoto Y; Kano M; Akutsu Y; Hanari N; Hoshino I; Murakami K; Usui A; Suito H; Takahashi M; Otsuka R; Xin H; Komatsu A; Iida K; Matsubara H
Oncol Rep; 2016 Nov; 36(5):2535-2543. PubMed ID: 27599779
[TBL] [Abstract][Full Text] [Related]
14. Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.
Cai XW; Yu WW; Yu W; Zhang Q; Feng W; Liu MN; Sun MH; Xiang JQ; Zhang YW; Fu XL
Cancer Med; 2018 Jun; 7(6):2504-2517. PubMed ID: 29683265
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration.
Gao DC; Hou B; Zhou D; Liu QX; Zhang K; Lu X; Zhang J; Zheng H; Dai JG
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6097-6110. PubMed ID: 32572925
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
[TBL] [Abstract][Full Text] [Related]
18. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
19. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
[TBL] [Abstract][Full Text] [Related]
20. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
